Emerald Mutual Fund Advisers Trust G1 Therapeutics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	BUY	$43.15 - $67.97 $5.28 Million - $8.32 Million	122,380 Added 34.76%	474,433 $24.8 Million
Q2 2018 Jul 31, 2018	SELL	$35.06 - $51.17 $8.33 Million - $12.2 Million	-237,702 Reduced 40.31%	352,053 $15.3 Million
Q1 2018 Apr 26, 2018	BUY	$19.05 - $41.76 $169,506 - $371,580	8,898 Added 1.53%	589,755 $21.9 Million
Q4 2017 Feb 06, 2018	BUY	$19.01 - $26.2 $53,228 - $73,360	2,800 Added 0.48%	580,857 $11.5 Million
Q3 2017 Oct 30, 2017	BUY	$12.53 - $27.12 $7.24 Million - $15.7 Million	578,057	578,057 $14.4 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.